CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,677 | +197.8% | 2,578,199 | +80.4% | 0.01% | +175.0% |
| Q2 2023 | $25,750 | +3731.8% | 1,428,910 | +3319.8% | 0.00% | – |
| Q1 2023 | $672 | -29.3% | 41,783 | -19.5% | 0.00% | – |
| Q4 2022 | $951 | -99.9% | 51,931 | -15.7% | 0.00% | – |
| Q3 2022 | $1,212,000 | +19.4% | 61,635 | +13.3% | 0.00% | – |
| Q2 2022 | $1,015,000 | +23.0% | 54,407 | +44.8% | 0.00% | – |
| Q1 2022 | $825,000 | -62.2% | 37,583 | -51.1% | 0.00% | – |
| Q4 2021 | $2,183,000 | +56.7% | 76,822 | +16.1% | 0.00% | – |
| Q3 2021 | $1,393,000 | +12.1% | 66,163 | +0.4% | 0.00% | – |
| Q2 2021 | $1,243,000 | +66.4% | 65,925 | +34.9% | 0.00% | – |
| Q1 2021 | $747,000 | -34.6% | 48,865 | -39.6% | 0.00% | – |
| Q4 2020 | $1,142,000 | -15.3% | 80,902 | -6.0% | 0.00% | – |
| Q3 2020 | $1,349,000 | -10.5% | 86,068 | 0.0% | 0.00% | – |
| Q2 2020 | $1,508,000 | +260.8% | 86,068 | +203.0% | 0.00% | – |
| Q1 2020 | $418,000 | -53.9% | 28,408 | -21.3% | 0.00% | – |
| Q4 2019 | $906,000 | +15.3% | 36,108 | -30.9% | 0.00% | – |
| Q3 2019 | $786,000 | -93.6% | 52,283 | -89.3% | 0.00% | -100.0% |
| Q2 2019 | $12,198,000 | +10.2% | 487,916 | +0.4% | 0.00% | 0.0% |
| Q1 2019 | $11,064,000 | -15.0% | 486,130 | +12.0% | 0.00% | 0.0% |
| Q4 2018 | $13,016,000 | +4.7% | 433,996 | +0.0% | 0.00% | 0.0% |
| Q3 2018 | $12,431,000 | – | 433,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 820,720 | $17,276,000 | 7.15% |
| 5AM Venture Management, LLC | 1,362,286 | $28,676,000 | 5.82% |
| Bain Capital Life Sciences Investors, LLC | 1,679,701 | $35,358,000 | 2.19% |
| Opaleye Management Inc. | 402,113 | $8,464,000 | 1.58% |
| FRAZIER MANAGEMENT LLC | 851,306 | $17,920,000 | 1.43% |
| Perceptive Advisors | 3,963,517 | $83,432,000 | 1.21% |
| Altium Capital Management LP | 193,000 | $4,063,000 | 1.07% |
| MPM BioImpact LLC | 298,392 | $6,281,000 | 0.97% |
| SPHERA FUNDS MANAGEMENT LTD. | 548,643 | $11,549,000 | 0.97% |
| Ghost Tree Capital, LLC | 150,000 | $3,158,000 | 0.92% |